Terms: = Leukemia AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Diagnosis
518 results:
1. Construction and experimental validation of a novel ferroptosis-related gene signature for myelodysplastic syndromes.
Zhu Y; He J; Wei R; Liu J
Immun Inflamm Dis; 2024 Apr; 12(4):e1221. PubMed ID: 38578040
[TBL] [Abstract] [Full Text] [Related]
2. Identification of red blood cell distribution width as a prognostic factor in acute myeloid leukemia.
Liu Q; Zhai Y; Hui Y; Chen J; Mi Y; Wang J; Wei H
Exp Hematol; 2024 May; 133():104206. PubMed ID: 38508299
[TBL] [Abstract] [Full Text] [Related]
3. An ensemble-acute lymphoblastic leukemia model for acute lymphoblastic leukemia image classification.
Huang ML; Huang ZB
Math Biosci Eng; 2024 Jan; 21(2):1959-1978. PubMed ID: 38454670
[TBL] [Abstract] [Full Text] [Related]
4. HLA-I levels correlate with survival outcomes in response to immune checkpoint inhibitors in non-small cell lung cancer.
Saigí M; Mate JL; Carcereny E; Martínez-Cardús A; Esteve A; Andreo F; Centeno C; Cucurull M; Mesia R; Pros E; Sanchez-Cespedes M
Lung Cancer; 2024 Mar; 189():107502. PubMed ID: 38359742
[TBL] [Abstract] [Full Text] [Related]
5. A tower of babel of acronyms? The shadowlands of MGUS/MBL/CHIP/TCUS.
Bravo-Perez C; Gurnari C
Semin Hematol; 2024 Feb; 61(1):43-50. PubMed ID: 38350765
[TBL] [Abstract] [Full Text] [Related]
6. Exploring risk factors and molecular targets in leukemia patients with COVID-19: a bioinformatics analysis of differential gene expression.
Ullah MA; Moin AT; Nipa JF; Islam NN; Johora FT; Chowdhury RH; Islam S
J Leukoc Biol; 2024 Mar; 115(4):723-737. PubMed ID: 38323674
[TBL] [Abstract] [Full Text] [Related]
7. Statistical performance review on diagnosis of leukemia, glaucoma and diabetes mellitus using AI.
Perumalraja R; Felcia Logan's Deshna B; Swetha N
Stat Med; 2024 Mar; 43(6):1227-1237. PubMed ID: 38247116
[TBL] [Abstract] [Full Text] [Related]
8. Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis.
Murru R; Galitzia A; Barabino L; Presicci R; La Nasa G; Caocci G
Ann Hematol; 2024 May; 103(5):1655-1664. PubMed ID: 38236391
[TBL] [Abstract] [Full Text] [Related]
9. Investigation of fatty acid metabolism in chronic lymphocytic leukemia to guide clinical outcome and therapy.
Pan B; Xu Z; Du K; Gao R; Zhang J; Yin H; Shen H; Liang J; Li Y; Wang L; Li J; Xu W; Wu J
Ann Hematol; 2024 Apr; 103(4):1241-1254. PubMed ID: 38150112
[TBL] [Abstract] [Full Text] [Related]
10.
Choi YJ; Min YK; Lee ST; Choi JR; Shin S
Ann Lab Med; 2024 Jul; 44(4):335-342. PubMed ID: 38145892
[TBL] [Abstract] [Full Text] [Related]
11. Label-free microfluidic chip for segregation and recovery of circulating leukemia cells: clinical applications in acute myeloid leukemia.
Ouyang D; Ye N; Jiang Y; Wang Y; Hu L; Chao S; Yarmush M; Tuner M; Li Y; Tang B
Biomed Microdevices; 2023 Dec; 26(1):3. PubMed ID: 38085348
[TBL] [Abstract] [Full Text] [Related]
12. [Immunophenotypic and Clinical Characteristics of
Liu SY; Zhu L; Wang CY; He C; Yi SJ; Meng L; Xiao M; Mao X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1639-1646. PubMed ID: 38071040
[TBL] [Abstract] [Full Text] [Related]
13. Test Then Erase? Current Status and Future Opportunities for Measurable Residual Disease Testing in Acute Myeloid leukemia.
Blackmon AL; Hourigan CS
Acta Haematol; 2024; 147(2):133-146. PubMed ID: 38035547
[TBL] [Abstract] [Full Text] [Related]
14. Synchronous presentation of
Khera S; Kurup A; Agarwal S; Tripathi P
BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 37967932
[TBL] [Abstract] [Full Text] [Related]
15. Deep learning predicts therapy-relevant genetics in acute myeloid leukemia from Pappenheim-stained bone marrow smears.
Kockwelp J; Thiele S; Bartsch J; Haalck L; Gromoll J; Schlatt S; Exeler R; Bleckmann A; Lenz G; Wolf S; Steffen B; Berdel WE; Schliemann C; Risse B; Angenendt L
Blood Adv; 2024 Jan; 8(1):70-79. PubMed ID: 37967385
[TBL] [Abstract] [Full Text] [Related]
16. Frequency of TP53 Mutation in B-Cell Chronic Lymphocytic Leukaemia and its Association with Lymphocyte Doubling Time.
Ali SM; Irfan SM; Raza N
J Coll Physicians Surg Pak; 2023 Nov; 33(11):1249-1253. PubMed ID: 37926876
[TBL] [Abstract] [Full Text] [Related]
17. Automated prediction of acute promyelocytic leukemia from flow cytometry data using a graph neural network pipeline.
Cox AM; Kim D; García R; Fuda FS; Weinberg OK; Chen W
Am J Clin Pathol; 2024 Mar; 161(3):264-272. PubMed ID: 37878540
[TBL] [Abstract] [Full Text] [Related]
18. Chronic myeloid leukaemia: A qualitative interview study exploring disease impact from patient and practitioner perspectives.
Hewison A; Roman E; Smith A; McCaughan D; Sheridan R; Patmore R; Atkin K; Howell D
Eur J Oncol Nurs; 2023 Dec; 67():102421. PubMed ID: 37804754
[TBL] [Abstract] [Full Text] [Related]
19. leukemia-associated aberrant immunophenotype: A flow cytometry-based experience of 110 cases from a tertiary care center in Northern India.
Venugopalan RK; Singh N; Anthony ML; Kunnumbrath A; Gupta AK; Nath UK; Chowdhury N; Chandra H
J Cancer Res Ther; 2023; 19(5):1335-1339. PubMed ID: 37787304
[TBL] [Abstract] [Full Text] [Related]
20. FCM marker importance for MRD assessment in T-cell acute lymphoblastic leukemia: An AIEOP-BFM-ALL-FLOW study group report.
Kowarsch F; Maurer-Granofszky M; Weijler L; Wödlinger M; Reiter M; Schumich A; Feuerstein T; Sala S; Nováková M; Faggin G; Gaipa G; Hrusak O; Buldini B; Dworzak MN
Cytometry A; 2024 Jan; 105(1):24-35. PubMed ID: 37776305
[TBL] [Abstract] [Full Text] [Related]
[Next]
